Nominations Committees’ Resolutions Series: #5 – The Importance of Improving Shareholder Communication
Open and effective communication regarding director appointments, executive committee appointments, succession plans, nomination governance and process, board evaluations, will all boosts transparency and good governance recognition which strengthen shareholders’ trust. Whichever communication approach, nominations committees should reassure shareholders of the sustainability of the board and executive management by disclosing relevant information.live streaming film Underworld: Blood Wars 2016
Nominations Committees’ Resolutions Series:#4 -An Induction Is not Enough
Any new job requires the appointee to assimilate critical information about how the company is run, what its business is and how the company can benefit from their experience. Non-executive directors are absolutely no different in this regard and company boards need to induct their new members effectively.
Nominations Committees’ Resolutions Series: #3 -Diversity Is not A Buzzword, It Is Fundamental Business
Board composition is a fundamental area that greatly concerns investors, both private and public. Board diversity has been a hot topic for several years. Supporters believe a diverse board significantly reduces blind spots and biases.
Nominations Committees’ Resolutions Series: #2- Board Effectiveness Calls for Recruitment Professionalism
Board appointment processes are often heavily influenced by people’s personal and professional networks, making it difficult to deliver a truly objective and balanced process. Sometimes, the recruitment becomes solely a matter of “who you know”? Due to the increased complexity of the corporate world and the professional vocation of directorships, Liftstream believes a clearly-structured recruiting process can be constructed, with a forward looking view for the business needs, to attract and recruit board members who will enhance the effectiveness of the board.
Nominations Committees’ Resolutions Series: #1- Board and Executive Succession Planning Must Be Forward Looking
Succession Planning should concern the nomination committee all year round, but the ticking over of the calendar is the perfect opportunity to appraise the sophistication of your succession planning.
Five Resolutions for Nominations Committees to Improve Board Performance
The New Year brings a period of reflection, what will you change in the year ahead and how will you do it? There are some clear ways in which the effectiveness of the board can be improved by the way in which the nominations and governance committee discharge their responsibilities. Here we listed 5 resolutions for an effective nominations committee. Click the following links to read detailed articles on each recommendation.
Liftstream Gets Even More Social
Liftstream was early to the social media party, which perhaps explains why we rank #2 among our competitors for Twitter followers and #3 for LinkedIn followers, chasing the #1 spot with your help.
Abide Therapeutics Names Chan Beals as Chief Medical Officer
Abide Therapeutics, a biotechnology company with research operations in San Diego and clinical development centre in Princeton, has appointed Chan Beals as Chief Medical Officer. In July 2015, Abide began enrolment in its first clinical study, a Phase 1a clinical study of ABX-1431, which is an investigational endocannabinoid system modulator with potential indications in symptomatic improvement in multiple sclerosis, neuroinflammation, acute and chronic pain, agitation in Alzheimer’s Disease and pain in irritable bowel syndrome. “With our first clinical study launched, the time is ideal to bring Beals aboard as we expand this program and advance our follow on first-in-class therapeutics,” commented Abide CEO Alan Ezekowitz.
China’s Simcere Plans Hong Kong IPO
Simcere Pharmaceutical Group, based in Jiangsu province, China, is preparing to raise as much as USD1 billion in a Hong Kong IPO in the third quarter, according to The Wall Street Journal. The firm did not release any official statement regarding the possible plan.
SV Life Sciences Appoints Joshua Resnick as Partner
SV Life Sciences (SVLS), a life sciences venture capital firm with offices in Boston, London and San Francisco, has appointed Joshua Resnick as Partner. Based in Boston, Resnick joins SVLS’ biotech investment team which partners with experienced entrepreneurs and accomplished management teams.
